Shanghai Jmt-bio Inc.

This study is testing a new drug called JMT108 for people with advanced melanoma that has spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug helps shrink tumors. The trial is open to adults whose cancer has continued to grow despite…

This study is testing a new drug called JMT108 in adults with advanced cancers that have not responded to standard treatments. The main goals are to find a safe dose, see how the body processes the drug, and look for early signs that it can shrink tumors. It is an early-stage tri…

This is the first human study of an experimental drug called JMT106 for people with advanced solid tumors, including certain lung and liver cancers. The main goal is to find a safe dose and see how the body handles the drug in about 200 participants who have run out of standard t…

This study is testing a new injectable drug called JMT202 to see if it is safe and can help lower high levels of triglycerides, a type of fat in the blood. It will involve about 48 Chinese adults with persistently high triglycerides. Participants will receive either the drug or a…

This is an early safety study for a new injection called JMT206. It will test single, increasing doses in 44 healthy volunteers to see how safe it is and how the body handles it. The main goal is to gather basic safety information, not to treat any disease.